Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2002
05/16/2002US20020058265 Analyzing preferential genetic mapping positions; obtain nucleotide sequences, incubate with primers, amplify nucleotide sequences, determine the size of the amplified nucleotide sequences
05/16/2002US20020058264 Human regulatory molecules
05/16/2002US20020058263 Generalized target-binding e-tag probe compositions
05/16/2002US20020058262 Method for determining the efficiency of nucleic acid amplifications
05/16/2002US20020058260 Screening for microbiocides; obtain sample, incubate with modulator, monitor sample for adjustment in cell proliferation
05/16/2002US20020058259 Regulation of human lipoxin A4 receptor-like protein
05/16/2002US20020058258 Monitoring hybridization during PCR using SYBR Green I
05/16/2002US20020058257 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
05/16/2002US20020058256 Method and apparatus for identifying, classifying, or quantifying protein sequences in a sample without sequencing
05/16/2002US20020058254 Screening methods for enzymes and enzyme kits
05/16/2002US20020058253 High affinity TCR proteins and methods
05/16/2002US20020058251 Observing the distribution of MN/CA9 antigen expressed on atypical or normal cells; atypical glandular cells of undetermined significance (AGUS)
05/16/2002US20020058250 Generating variable numbers of tandem repeats for use as diagnostic tool in genetic analysis; obtain genomic nucleotide sequences, join to adaptor, amplify nucleotide sequences, recover sequence products
05/16/2002US20020058249 Dna shuffling to produce herbicide selective crops
05/16/2002US20020058246 Screening enzymatic polypeptides for use in detergents; obtain microorganism expressing polypeptides, incubate with detergent, expose to binding protein, separate bound complex, isolate and propagate genome coding enzymatic variant
05/16/2002US20020058243 Nucleotide sequences for use tools in heterologous gene expression
05/16/2002US20020058241 Antibody for use in the treatment of prostate cancer
05/16/2002US20020058045 Constructing a fiber-mutant adenovirus vector by introducing a foreign peptide into the HI loop of the fiber of the virus.
05/16/2002US20020058042 Non-IgA fc binding forms of the Group B streptococcal beta antigens
05/16/2002US20020058038 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes.
05/16/2002US20020058036 Novel fibroblast growth factor and nucleic acids encoding same
05/16/2002US20020058033 Human anti-epidermal growth factor receptor single-chain antibodies
05/16/2002US20020058024 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
05/16/2002US20020058022 Novel compounds
05/16/2002US20020058020 Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins
05/16/2002DE10145134A1 Komplexe zur Einführung von Nukleinsäuren in Zellen Complex for the introduction of nucleic acids into cells
05/16/2002DE10110344A1 Fermentative production of L-amino acids, especially lysine or valine, by fermenting Coryneform bacteria in which the nadA and/or nadC gene is weakened
05/16/2002DE10054639A1 Spezifischer Co-Aktivator für humane nukleäre Rezeptoren Specific co-activator for human nuclear receptors
05/16/2002DE10054303A1 Analoga, Agonisten, Antagonisten und Varianten der Oxidoreduktase-Enzymaktivität des Makrophagen-Migrations-Inhibitions-Faktors (MIF) als Immunmodulatoren, Therapeutika, Diagnostika und Screening-Agenzien bei inflammatorischen und Immunerkrankungen Analogues, agonists, antagonists, and variants of the oxidoreductase enzyme activity of macrophage migration inhibitory factor (MIF) as immunomodulators, therapeutic agents, diagnostic and screening agents in inflammatory and immune diseases
05/16/2002DE10046932A1 Expression system for increased production of copper-dependent enzymes, particularly laccase, includes the gene for a copper homeostasis protein
05/16/2002CA2454383A1 Monocotyledonous plant transformation
05/16/2002CA2437942A1 Chimeric molecules to modulate gene expression
05/16/2002CA2436200A1 Dna sequences encoding proteins conferring phytophthora infestans resistance on plants
05/16/2002CA2431997A1 Method of identifying antibacterial compounds
05/16/2002CA2429073A1 Novel method for analysing phenotypic characteristics of human immunodeficiency virus (hiv)
05/16/2002CA2428543A1 Methods of screening for ltrpc2 modulators
05/16/2002CA2428492A1 Method for screening agents by modulating the expression of sparc
05/16/2002CA2428453A1 C. elegans genes involved in viability and/or reproduction and uses thereof
05/16/2002CA2428368A1 Kit and method for detecting the esm-1 protein
05/16/2002CA2428326A1 Mammalian sex selection using genetic modification
05/16/2002CA2428282A1 Methods for regulating plant gaba production
05/16/2002CA2428259A1 Barley with reduced ssii activity and starch and starch containing products with a reduced amylopectin content
05/16/2002CA2428245A1 A new assay for the detection and quantitation of hemimethylation
05/16/2002CA2428242A1 Human tumor necrosis factor receptor
05/16/2002CA2428241A1 Novel human potassium channel beta subunit
05/16/2002CA2428161A1 Substances causing differentiation
05/16/2002CA2428155A1 Method for removing a universal linker from an oligonucleotide
05/16/2002CA2428146A1 A plant development regulating gene and its uses
05/16/2002CA2428114A1 Apolipoprotein analogues
05/16/2002CA2427825A1 Putrescine-n-methyltransferase promoter
05/16/2002CA2427117A1 A transformation system in camelina sativa
05/16/2002CA2426871A1 Method and device for selectively targeting cells within a three -dimensional specimen
05/16/2002CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
05/16/2002CA2426035A1 Streptavidin-binding peptides and uses thereof
05/16/2002CA2426030A1 Methods of treating disorders related to apoe
05/16/2002CA2425980A1 Foggy
05/16/2002CA2425829A1 Proteases
05/16/2002CA2399276A1 Novel therapeutic compositions for treating infection by lawsonia spp
05/15/2002EP1205556A1 Process for the preparation of trans-carveol
05/15/2002EP1205554A1 Enzyme or cell preparation with inulinase activity
05/15/2002EP1205553A1 Nucleotide sequences encoding the sigD gene
05/15/2002EP1205552A1 Virulence of streptococci, involving ORFs from Streptococcus suis
05/15/2002EP1205551A1 Growth hormone and growth hormone releasing hormone compositions
05/15/2002EP1205550A1 Polypeptides and nucleic acids encoding the same
05/15/2002EP1205549A1 Gene expressed specifically in human fetal heart muscle
05/15/2002EP1205548A1 Methods and apparatus for successively ligating double-stranded DNA molecules on a solid phase
05/15/2002EP1205547A2 DNA mutagenesis by random fragmentation and reassembly
05/15/2002EP1205546A1 Polypeptide and nucleic acids encoding the same
05/15/2002EP1205545A1 Enzymes with beta-(1,6)-endoglucanase activity
05/15/2002EP1205543A1 DNA sequences encoding proteins conferring Phytophthora infestans resistance on plants
05/15/2002EP1205542A1 L-amino acid oxidase from Rhodococcus
05/15/2002EP1205490A1 Fusion protein comprising integrase (phiC31) and a signal peptide (NLS)
05/15/2002EP1205489A1 Polypeptide and nucleic acids encoding the same
05/15/2002EP1205191A1 Targeted modification of intracellular compounds
05/15/2002EP1204868A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods
05/15/2002EP1204867A1 Microarrays and their manufacture
05/15/2002EP1204864A2 Apparatus for real-time measurement of cellular response
05/15/2002EP1204790A1 Microelectromechanical devices useful for manipulating cells or embryos, kits thereof, methods of making same, and methods of use thereof
05/15/2002EP1204765A2 Method for relative quantization of methylation of cytosin-type bases in dna samples
05/15/2002EP1204764A2 Methods of screening for angiogenesis modulators
05/15/2002EP1204763A2 Method for characterizing nucleic acid fragments
05/15/2002EP1204762A1 D-gluconolactone oxidase gene and method for producing recombinant d-gluconolactone oxidase
05/15/2002EP1204761A2 Targeted artificial gene delivery
05/15/2002EP1204760A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy
05/15/2002EP1204759A2 Modified plants
05/15/2002EP1204758A2 Use of aspergillus sojae as host for recombinant protein production
05/15/2002EP1204757A1 Neutral cerebral-sphingomyelinase
05/15/2002EP1204756A2 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase
05/15/2002EP1204755A2 Process for the biological production of 1,3-propanediol
05/15/2002EP1204754A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
05/15/2002EP1204753A2 Invasive bacteria based viral vaccines
05/15/2002EP1204752A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
05/15/2002EP1204750A1 Basb126 polypeptide and polynucleotide from moraxella catarhalis
05/15/2002EP1204749A2 Moraxella catarrhalis antigens basb122 and basb124
05/15/2002EP1204748A2 New g-protein coupled receptor and dna sequences thereof
05/15/2002EP1204747A1 G protein-coupled receptor expressed in brain
05/15/2002EP1204746A2 Sentrin-specific human proteases senp1-3
05/15/2002EP1204745A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations
05/15/2002EP1204744A1 Isolated peptide of the horny layer and use thereof
05/15/2002EP1204743A2 Methods of inhibiting cancer cells with adnf iii antisense oligonucleotides